Delivery Order SPE2DB20D2001-SPE2DB23FM72S

Award Date 9/12/23
Potential Completion Date 9/13/23
Potential Value $5.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of 4,566,570,695 units of Abiraterone Acetate 500 mg tablets to the Defense Logistics Agency (DLA). The $14,550.27 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 29, 2024, with a completion date of December 2, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,679.26 firm fixed-price delivery order is for the supply of 4,565,672,909 units of abiraterone acetate 250 mg tablets. The award has a completion date of September 5, 2024 and was made on September 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $94,299.16 for the procurement of 4,566,862,217 units of abiraterone acetate 250 mg tablets. The award was made to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $6,887.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for 4,563,352,653 units of Abiraterone Acetate 500 mg tablets. The contract has an ultimate completion date of January 19, 2024, and is a firm-fixed-price contract type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, to provide 4,564,755,143 units of Abiraterone Acetate 500 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award, valued at $1,842.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of abiraterone acetate 250 mg tablets, a medication used in the treatment of prostate cancer. The contract is a firm fixed-price delivery order, with a period of performance extending through February 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $1,481.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,566,734,838 units of Abiraterone Acetate 500 mg tablets. This is a Firm Fixed Price delivery order with a completion date of December 17, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,065.66 delivery order contract is for the supply of 4562280566 - Abiraterone Acetate 500 mg Tablets, 60-count. The contract has a completion date of September 25, 2023 and uses a Firm Fixed Price pricing type. This award appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $1,822.78, is for the delivery of 4565133468 - Abiraterone Acetate 250 mg Tablets. The award is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,667.28 firm fixed price delivery order contract (SPE2DB22D1017|SPE2DB24FF5LH) to provide 4,564,184,345 units of Abiraterone Acetate 250 mg tablets. This delivery order is under an indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB23FM72S
    Delivery Order

The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of abiraterone acetate 250 mg tablets. The contract, valued at $5,917.04, is a delivery order placed by the Defense Logistics Agency (DLA) Troop Support Medical. It has an ultimate completion date of September 13, 2023. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/27/25, 10:38 AM